Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor, Esophageal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07722819
What this trial is testing

ESCC Molecular Subtypes Based on Multidimensional Features of p53 and Their Clinical Significance

Who this might be right for
P53 Mutation in Esophageal Cancer
Ling Zhiqiang 300
Early research (Phase 1)Study completedNCT02642809
What this trial is testing

Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers

Who this might be right for
Esophageal CancerCancer of the Esophagus
Washington University School of Medicine 16
Testing effectiveness (Phase 2)Study completedNCT03611712
What this trial is testing

PG2 Concurrent With Chemoradiation for Locally Advanced Esophageal Cancer

Who this might be right for
Cancer-related FatigueSurvivalTumor, Esophageal
PhytoHealth Corporation 48
Not applicableUnknownNCT04504565
What this trial is testing

99m Tc-3PRGD2 SPECT/CT Imaging in the Diagnosis of Lymph Node Metastasis of Esophageal Carcinoma

Who this might be right for
Esophageal CancerLymph Node MetastasesDiagnoses Disease
Fifth Affiliated Hospital, Sun Yat-Sen University 30
Testing effectiveness (Phase 2)Study completedNCT04568200
What this trial is testing

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking Union Medical College Hospital 60
Not applicableStudy completedNCT01657175
What this trial is testing

Quality of Life After Oesophageal or Gastric Cancer Surgery

Who this might be right for
Quality of LifeOesophageal CancerGastric Cancer
Region Skane 82
Testing effectiveness (Phase 2)Study completedNCT00681330
What this trial is testing

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Tokyo University 14
Early research (Phase 1)Looking for participantsNCT07334119
What this trial is testing

Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors

Who this might be right for
HER2-Expressing Solid Tumors
Myeloid Therapeutics 60
Testing effectiveness (Phase 2)Looking for participantsNCT04592211
What this trial is testing

Pembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) Cancer

Who this might be right for
Gastric Cancer Stage IV
Yonsei University 71
Early research (Phase 1)Study completedNCT04958044
What this trial is testing

Endoscopic Assisted Calcium Electroporation in Esophageal Cancer

Who this might be right for
Esophageal Cancer
Michael Patrick Achiam 10
Not applicableUnknownNCT06349044
What this trial is testing

A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.

Who this might be right for
Her-2 Negative Adenocarcinoma of the Gastro-oesophageal Junction/Gastric AdenocarcinomaHepatocellular CarcinomaBiliary Tract Carcinoma+1 more
Zhejiang Cancer Hospital 120
Testing effectiveness (Phase 2)Looking for participantsNCT07189871
What this trial is testing

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more
Radiopharm Theranostics, Ltd 61
Not applicableStudy completedNCT02066701
What this trial is testing

Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers

Who this might be right for
Barrett's Esophagus
Mayo Clinic 250
Not applicableUnknownNCT02950324
What this trial is testing

Does Prehabilitation Improve Exercise Performance and Insulin Resistance After Surgery for Oesophago-gastric Cancer?

Who this might be right for
Cancer
Royal Surrey County Hospital NHS Foundation Trust 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03421288
What this trial is testing

Study of Atezolizumab + FLOT vs. FLOT Alone in Patients With GC/GEJ and High Immune Responsiveness

Who this might be right for
Gastric CancerGastroesophageal Junction Adenocarcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 677
Testing effectiveness (Phase 2)UnknownNCT05170542
What this trial is testing

The Neoadjuvant Treatment of Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma.

Who this might be right for
Efficacy and Safty of Camrelizumab Plus S-1 Maintenance After First-line Induction Chemotherapy for GC
Peking Union Medical College Hospital 42
Early research (Phase 1)Looking for participantsNCT07085091
What this trial is testing

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)HNSCCCRC (Colorectal Cancer)+4 more
ALX Oncology Inc. 170
Not applicableLooking for participantsNCT06430346
What this trial is testing

Exercise Prehabilitation for Locoregional Esophageal Cancer

Who this might be right for
Esophageal Cancer
H. Lee Moffitt Cancer Center and Research Institute 20
Large-scale testing (Phase 3)Study completedNCT03997188
What this trial is testing

Zinc-L-Carnosine Prevents Dysphagia in Breast Cancer Patients Undergoing Adjuvant Radiotherapy

Who this might be right for
Breast Cancer FemaleDysphagiaAdjuvant Radiotherapy
Cynthia Aristei 40
Testing effectiveness (Phase 2)WithdrawnNCT03818997
What this trial is testing

Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer

Who this might be right for
Esophageal CancerBiliary Tract CancerGastroEsophageal Cancer+1 more
European Organisation for Research and Treatment of Cancer - EORTC
Next Page